Title : Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.

Pub. Date : 2021 Feb

PMID : 33461143






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-kappaB-Nrf2 signaling in colorectal cancer cell. dihydromyricetin NFE2 like bZIP transcription factor 2 Homo sapiens
2 BACKGROUD: Dihydromyricetin (DMY), a natural flavonoid compound from the leaves of the Chinese medicinal herb Vitis heyneana, has been shown to have the potential to combat chemoresistance by inhibiting Nrf2/MRP2 signaling in colorectal cancer (CRC) cells. dihydromyricetin NFE2 like bZIP transcription factor 2 Homo sapiens
3 BACKGROUD: Dihydromyricetin (DMY), a natural flavonoid compound from the leaves of the Chinese medicinal herb Vitis heyneana, has been shown to have the potential to combat chemoresistance by inhibiting Nrf2/MRP2 signaling in colorectal cancer (CRC) cells. dihydromyricetin NFE2 like bZIP transcription factor 2 Homo sapiens
4 Furthermore, DMY could inhibit NF-kappaB/p65 expression, reducing NF-kappaB/p65 translocation to the nucleus to silence Nrf2 signaling, which is necessary for MRP2 expression. dihydromyricetin NFE2 like bZIP transcription factor 2 Homo sapiens